- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Windtree Therapeutics Inc (WINT)
Windtree Therapeutics Inc stock price live, this page displays OTC WINT stock exchange data. View the WINT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Windtree Therapeutics Inc real time stock price chart below.
What Is the Windtree Therapeutics Inc Stock Price Today?
The Windtree Therapeutics Inc stock price today is 0.096.
What Is the Stock Symbol for Windtree Therapeutics Inc?
The stock symbol for Windtree Therapeutics Inc is ""WINT.""
What Stock Exchange Does Windtree Therapeutics Inc Trade On?
Windtree Therapeutics Inc is listed and trades on the OTC Markets stock exchange.
Is Windtree Therapeutics Inc a Good Stock to Buy?
Determining whether Windtree Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WINT quote. (ISIN: US97382D6004)
What Is the Windtree Therapeutics Inc Stock Price Today?
The Windtree Therapeutics Inc stock price today is 0.096.
What Is the Stock Symbol for Windtree Therapeutics Inc?
The stock symbol for Windtree Therapeutics Inc is ""WINT.""
What Stock Exchange Does Windtree Therapeutics Inc Trade On?
Windtree Therapeutics Inc is listed and trades on the OTC Markets stock exchange.
Is Windtree Therapeutics Inc a Good Stock to Buy?
Determining whether Windtree Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WINT quote. (ISIN: US97382D6004)
OTC Markets
Currency in USD
0.096
0.000(0.00%)
Delayed Data·
Fair Value
An estimate of a Windtree Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.096
0.100
52 wk Range
0.090
449.500
WINT Scorecard
Full Analysis
Operates with a significant debt burden
WINT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Windtree Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0960.100
52 wk Range
0.090449.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
WINT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Windtree Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form 8K Windtree Therapeutics Inc For: 20 August
- Investing.com
- Form 8K Windtree Therapeutics Inc For: 5 August
- Investing.com
- Form 8K Windtree Therapeutics Inc For: 20 August
- Investing.com
- Form 8K Windtree Therapeutics Inc For: 5 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Windtree Therapeutics Inc Company Profile
Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trials to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant for the treatment of respiratory disease, disorder, or condition in humans; Rostafuroxin, which is in Phase 2b clinical trials for the treatment of genetically associated hypertension; and oral and intravenous SERCA2a activators, which are in preclinical trials for the treatment of chronic and acute heart failure. In addition, it is developing an aPKCi inhibitor, which is in preclinical trials for the treatment of cutaneous malignancies and solid tumors. Windtree Therapeutics, Inc. has a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sale of a portfolio of potential KL4 surfactant products; a license, development, and commercialization agreement with Lee’s Pharmaceutical (HK) Ltd. and Zhaoke Pharmaceutical (Hefei) Co. Ltd.; a license agreement with Philip Morris USA, Inc. and Johnson & Johnson; and a collaboration with Battelle Memorial Institute for the development of its aerosol delivery system. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania.
Compare WINT to Peers and Sector
Metrics to compare | WINT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWINTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −2.7x | −0.6x | |
PEG Ratio | - | 0.03 | 0.00 | |
Price/Book | 0.9x | 2.4x | 2.6x | |
Price / LTM Sales | - | 8.7x | 3.3x | |
Upside (Analyst Target) | - | 175.1% | 39.1% | |
Fair Value Upside | Unlock | 8.5% | 5.4% | Unlock |
Earnings
Latest Release
Aug 19, 2025
EPS / Forecast
-3.06 / -0.11
Revenue / Forecast
-- / 3.00M
People Also Watch
FAQ
What Stock Exchange Does Windtree Therapeutics Trade On?
Windtree Therapeutics is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Windtree Therapeutics?
The stock symbol for Windtree Therapeutics is "WINT."
What Is the Windtree Therapeutics Market Cap?
As of today, Windtree Therapeutics market cap is 1.17M.
What Is Windtree Therapeutics's Earnings Per Share (TTM)?
The Windtree Therapeutics EPS (TTM) is -15.31.
From a Technical Analysis Perspective, Is WINT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Windtree Therapeutics Stock Split?
Windtree Therapeutics has split 8 times.
How Many Employees Does Windtree Therapeutics Have?
Windtree Therapeutics has 14 employees.
What is the current trading status of Windtree Therapeutics (WINT)?
As of 29 Aug 2025, Windtree Therapeutics (WINT) is trading at a price of 0.096, with a previous close of 0.10. The stock has fluctuated within a day range of 0.096 to 0.100, while its 52-week range spans from 0.090 to 449.500.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.